Consumer demand for OTC products (mouthwashes, toothpaste, sprays, lozenges) remains strong, as these are easily accessible and perceived as sufficient for mild or physiological halitosis. However, for more severe or pathological cases, prescription interventions (antibiotics, antiseptics, antacids), professional dental or medical treatment, and lifestyle change become critical. In the US Halitosis Treatment Market, efficacy, safety profiles, side effects, regulatory oversight, and consumer education all factor into whether OTC solutions are overused or misused. OTC products tend to target symptoms (bad odor) whereas prescription or professional treatments aim at root causes—gum disease, tongue coating, systemic disease. Also, OTC routes are subject to less regulatory scrutiny and fewer clinical trials; prescription treatments have higher costs and possibly more rigorous oversight. In developing future product pipelines, manufacturers must demonstrate robust clinical data, safety especially in long-term use, minimal resistance or side-effects, and clear labeling.

In group discussion, evaluate how to decide when OTC remains suitable and when prescription is warranted. What standards of evidence should underpin OTC product claims? Should regulatory agencies strengthen oversight of OTC halitosis products? Also, think about consumer education: do people understand the difference? Lastly, consider how payors (insurance) treat prescription vs OTC in terms of reimbursement.